The Journal of KAIRB (대한기관윤리심의기구협의회지)

Korean Association of Institutional Review Boartds (대한기관윤리심의기구협의회)
권호 표지

Comparison and Implications of Single Institutional Review Board and Human Research Protection Program in the United States and Korea

미국과 한국의 Single Institutional Review Board와 Human Research Protection Program의 비교와 함의

  • Ock-Joo Kim (Department of the History of Medicine and Medical Humanities, College of Medicine, Seoul National University, Center for Human Research Protection Seoul National University Hospital)
  • 김옥주 (서울대학교 의과대학 인문의학교실, 서울대학교병원 임상연구윤리센터)
  • Received : 2023.02.17
  • Accepted : 2023.02.21
  • Published : 2023.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

In the United States (US), due to the Common Rule, completely revised in 2017, single Institutional Review Board (IRB) review has become mandatory for government-sponsored multi-institutional research since 2020 regardless of the number of participating institutions. The goal of these changes is to reduce redundant reviews by the IRB at each institution and better protect research participants. In this paper, single IRB and Human Research Protection Program (HRPP) in the US and Korea were compared and considered, and their implications were discussed. A comparison of the HRPP evaluation and certification systems of the US and Korea includes that of SMART IRB in the US and Korea Central IRB, aiming at single IRB review for efficient review with support from the country and building a more efficient national human subject research network in the future. Its comparison and analysis will be helpful in deriving future tasks and development directions of single IRB and HRPP in Korea.

Keywords

References

  1. Park JY. Daegu Catholic University Medical Center . K Medi Hub held FERCAP 2022 Conference. Medical News [Internet]. 2022 Nov 29 [cited 2023 Feb 7]. Available from: http://www.bosa.co.kr/news/articleView.html?idxno=2186002.
  2. Borasky DA. Promoting a SMART IRB System. November 29, 2022. Paper presented at: The 22nd FERCAP International Conference; 2022 Nov 27-30; Daegu, Korea. Hosted by Daegu Catholic University Medical Center (DCUMC) Co-Organized with K-MEDI Hub: Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF) KAIRB, Daegu City, DCVB.
  3. Jung J, Kim OJ. Reformed U.S. Common Rule and current trends in human subject protection policy. J Korean Bioeth Assoc 2017;18:63-82.
  4. Choe BI. Implementation of the Revised Common Rule in the United States and its implications for Human Research in Korea. J KAIRB 2020;2:1-5.
  5. Ministry of Food and Drug Safety. Central IRB officially launched for rapid clinical entry! Press release 2021-07-30 [Internet]. Cheongju (Korea): Ministry of Food and Drug Safety; 2021 [cited 2023 Feb 7]. Available from: https://www.mfds.go.kr/brd/m_99/view.do?seq=45624&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1.
  6. Park SY, Noh YH, Cho SJ, Shim KY, Park EY, Kim JS. A Survey on current status and introduction of single Institutional Review Board (IRB) in Korea. J KAIRB 2020;2:6-22.
  7. Jung J, Kim JH, Jung SH, Kim OJ. Toward effective human research protection: the current status and limitations of the Human Research Protection Program in Korea. Korean J Med Eth 2017;20:163-75. https://doi.org/10.35301/ksme.2017.20.2.163
  8. Maeng CH, Lee SJ, Cho SR, Kim JS, Rha SY, Kim YJ, et al. Survey of operation and status of the Human Research Protection Program (HRPP) in Korea (2019). J KAIRB 2020;2:37-48.
  9. Park S, Cho SJ, Seo KJ, Kim JS. A survey on the current status of Human Research Protection Program settlement and subject protection activities in Korea. J KAIRB 2021;3:28-36.
  10. Park SY, Kim JS. The Korea Human Research Protection Program: present and future direction. J KAIRB 2022;4:30-5.
  11. Ministry of Food and Drug Safety. Guidance for operating Human Research Protection Program. Cheongju (Korea): Ministry of Food and Drug Safety; 2014 [cited 2023 Feb 8]. Available from: https://www.mfds.go.kr/brd/m_1060/view.do?seq=12203&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=102
  12. Corneli A, Dombeck CB, McKenna K, Calvert SB. Stakeholder experiences with the single IRB review process and recommendations for Food and Drug Administration guidance. Ethics Hum Res 2021;43:26-36. https://doi.org/10.1002/eahr.500092
  13. U.S. Food and Drug Administration. Using a centralized IRB review process in multicenter clinical trials [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2006 [cited 2023 Feb 7]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/using-centralized-irb-review-process-multicenter-clinical-trials.
  14. WCG IRB [Internet]. Puyallup (WA): WCG IRB; 2023 [cited 2023 Feb 7]. Available from: https://www.wcgirb.com/.
  15. Korean Food and Drug Administration. Food and Drug Administration Notification 2007-4. Good Clinical Practice 2007.1.19. Article 9-2. https://mfds.go.kr/brd/m_207/view.do?seq=2311&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=175
  16. Korean Food and Drug Administration. Food and Drug Administration Notification 2007-4. Good Clinical Practice 2007.1.19. Article 9-2 [Internet]. Cheongju (Korea): Ministry of Food and Drug Safety; 2007 [cited 2023 Feb 7]. Available from: https://mfds.go.kr/brd/m_207/view.do?seq=2311&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=175.
  17. Ministry of Food and Drug Safety. Notice No. 2016-133. Notification of partial revision of 'Regulations on Designation of Clinical Trials and Bioequivalence Trial Personnel Training and Training Institutions' [Internet]. Cheongju (Korea): Ministry of Food and Drug Safety; 2016 [cited 2023 Feb 7]. Available from: https://mfds.go.kr/brd/m_211/view.do?seq=11326&srchFr=&srchTo=&srchWord=%EC%9E%84%EC%83%81%EC%8B%9C%ED%97%98+%EB%B0%8F+%EC%83%9D%EB%AC%BC%ED%95%99%EC%A0%81+%EB%8F%99%EB%93%B1%EC%84%B1%EC%8B%9C%ED%97%98&srchTp=0&itm_seq_2=0&multi_itm_seq= 0&company_cd=&company_nm=&Data_stts_gubun=C9999& page=1
  18. SMART IRB [Internet]. Boston (MA); SMART IRB; [cited 2023 Feb 7]. Available from: https://smartirb.org/.
  19. Korean Academy of Medical Sciences. Clinical Trial Safety Support Institution, Central Institutional Review Board Manual Ver.2.0 [Internet]. Seoul (Korea): Korean Academy of Medical Sciences; 2023 [cited 2023 Feb 7]. Available from: https://cirb.kams.or.kr.
  20. Harvard Catalyst [Internet]. Boston (MA); Harvard Catalyst; 2023 [cited 2023 Feb 7]. Available from: https://catalyst.harvard.edu/about/.
  21. Cobb N, Witte E, Cervone M, Kirby A, MacFadden D, Nadler L, et al. The SMART IRB platform: a national resource for IRB review for multisite studies. J Clin Transl Sci 2019;3:129-39. https://doi.org/10.1017/cts.2019.394
  22. Office for Human Research Protections (OHRP). Practical and Ethical Considerations for Single IRB Review: an Exploratory Workshop [Internet]. Rockville (MD): OHRP; 2020 [cited 2023 Feb 8]. Available from: https://www.hhs.gov/ohrp/sites/default/files/2020-exploratory-workshop-summary-irb.pdf
  23. Murray A, Pivovarova E, Klitzman R, Stiles DF, Appelbaum P, Lidz CW. Reducing the single IRB Burden: streamlining electronic IRB systems. AJOB Empir Bioeth 2021;12:33-40. https://doi.org/10.1080/23294515.2020.1818877
  24. Serdoz ES, Edwards T, Pulley J, Beadles J, Ozier J, Harris P, et al. The IRB Reliance Exchange (IREx): a national web-based platform for operationalizing single IRB review. J Clin Transl Sci 2022;6:e39.
  25. Burr JS, Johnson A, Risenmay A, Bisping S, Serdoz ES, Coleman W, et al. Demonstration project: transitioning a research network to new single IRB Platforms. Ethics Hum Res 2022;44:32-8. https://doi.org/10.1002/eahr.500149
  26. Lowe AE, Kraft C, Kortepeter MG, Hansen KF, Sanger K, Johnson A, et al. Developing a rapid response single IRB model for conducting research during a public health emergency. Health Secur 2022;20(S1):S60-70. https://doi.org/10.1089/hs.2021.0181
  27. Harmonization [Internet]. Boston (MA); SMART IRB; 2023 [cited 2023 Feb 7]. Available from: https://smartirb.org/harmonization/.
  28. Office for Human Research Protections (OHRP). Use of a single Institutional Review Board for cooperative research. Draft [Internet]. Rockville (MD): OHRP; 2022 [cited 2023 Feb 8]. Available from: https://www.hhs.gov/ohrp/regulations-and-policy/requests-for-comments/draft-guidance-use-single-institutional-review-board-for-cooperative-research/index.html.
  29. The Secretary's Advisory Committee on Human Research Protections (SACHRP), Recommendations on the Draft Guidance for Use of Single Institutional Review Board for Cooperative Research [Internet]. Rockville (MD): OHRP; 2022 [cited 2023 Feb 8]. Available from: https://www.hhs.gov/ohrp/sachrp-committee/recommendations/attachment-a-july-25-2022-letter/index.html.
  30. Kim OJ. Introduction and establishment of Korean HRPP. 2017 March. Report to the Ministry of Food and Drug Safety Korea. Report No.: 16182한임평447 [Internet]. Cheongju (Korea): National Center for Medical Information and Knowledge; 2017 [cited 2023 Feb 8]. Available from: https://library.nih.go.kr/ncmiklib/synap/skin/doc.html?fn=323ac58584c28df85b08413fbe674071e11b1e9e767eb5ceace3392d22de77d8&rs=/ncmiklib/ncmik/st1/synap/202302&fileKey=82248.